Revenue Breakdown
Composition ()
No data
Revenue Streams
Teleflex Inc (TFX) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Interventional, accounting for 29.2% of total sales, equivalent to $266.41M. Other significant revenue streams include Vascular access and Surgical. Understanding this composition is critical for investors evaluating how TFX navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Teleflex Inc maintains a gross margin of 56.24%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.84%, while the net margin is 2.94%. These profitability ratios, combined with a Return on Equity (ROE) of 1.58%, provide a clear picture of how effectively TFX converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TFX competes directly with industry leaders such as CELC and TMDX. With a market capitalization of $5.43B, it holds a leading position in the sector. When comparing efficiency, TFX's gross margin of 56.24% stands against CELC's N/A and TMDX's 58.11%. Such benchmarking helps identify whether Teleflex Inc is trading at a premium or discount relative to its financial performance.
